As cardiac metabolism shifts from fatty acid oxidation to glycolysis during heart failure, Cpt1b-targeted therapy was used as a therapeutic approach in inhibiting fatty acid oxidation to treat heart failure [50]. Here, CPT1B is linked to heart failure.